ARCHIVES

Post-Hoc Analysis of ThermoDox Suggests OS Improvement

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

Conversation with The Cancer Letter: Kazerooni: The Case for Broad Coverage

March 21, 2014

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

Cancer Facts & Figures: Cancer Mortality Down 20 Percent Since 1991

January 25, 2013

ACCC Seeks Expanded Backing For CHOP, Other Community Cancer Programs

November 7, 1980

Research Advocates Prepare to Face Republican-led Congress

December 19, 2014